Skip to main content
. 2019 Dec 26;47(3):665–673. doi: 10.1007/s00259-019-04635-7

Table 1.

Patient characteristics. PSA, prostate-specific antigen; S-Testo, serum testosterone; cT, clincal T stage; cN, clinical N stage; cM, clinical M stage according to PSMA-PET

Age (years) PSA (μg/l) S-Testo (nmol/L) Gleason score cT cN cM
Patient 1 64 21 26 4 + 5 2c 1 1
Patient 2 69 25 13 4 + 5 3a 0 0
Patient 3 69 7 19 5 + 5 3a 0 0
Patient 4 77 7 7 4 + 5 1b 1 1
Patient 5 66 280 10 4 + 5 2a 0 1
Patient 6 71 52 9 5 + 4 3a 1 1
Patient 7 78 54 23 5 + 4 4 1 0
Patient 8 70 26 18 5 + 4 1b 1 1
Patient 9 70 9 12 5 + 3 2a 0 0